Susquehanna International Group’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $230K | Sell |
51,090
-9,570
| -16% | -$43.2K | ﹤0.01% | 5378 |
|
|
2025
Q1 | $269K | Buy |
60,660
+32,171
| +113% | +$143K | ﹤0.01% | 5158 |
|
|
2024
Q4 | $223K | Buy |
+28,489
| New | +$223K | ﹤0.01% | 5152 |
|
|
2024
Q2 | – | Sell |
-22,415
| Closed | -$364K | – | 6713 |
|
|
2024
Q1 | $364K | Buy |
22,415
+5,775
| +35% | +$93.9K | ﹤0.01% | 3934 |
|
|
2023
Q4 | $113K | Sell |
16,640
-6,070
| -27% | -$41.4K | ﹤0.01% | 5294 |
|
|
2023
Q3 | $124K | Sell |
22,710
-26,309
| -54% | -$143K | ﹤0.01% | 4824 |
|
|
2023
Q2 | $333K | Buy |
49,019
+186
| +0.4% | +$1.26K | ﹤0.01% | 4116 |
|
|
2023
Q1 | $245K | Buy |
48,833
+14,199
| +41% | +$71.1K | ﹤0.01% | 4651 |
|
|
2022
Q4 | $169K | Sell |
34,634
-4,034
| -10% | -$19.7K | ﹤0.01% | 4610 |
|
|
2022
Q3 | $558K | Buy |
38,668
+17,042
| +79% | +$246K | ﹤0.01% | 3383 |
|
|
2022
Q2 | $327K | Sell |
21,626
-12,791
| -37% | -$193K | ﹤0.01% | 3889 |
|
|
2022
Q1 | $409K | Buy |
34,417
+4,137
| +14% | +$49.2K | ﹤0.01% | 3961 |
|
|
2021
Q4 | $491K | Buy |
30,280
+3,701
| +14% | +$60K | ﹤0.01% | 3839 |
|
|
2021
Q3 | $759K | Buy |
26,579
+10,632
| +67% | +$304K | ﹤0.01% | 3115 |
|
|
2021
Q2 | $539K | Sell |
15,947
-3,379
| -17% | -$114K | ﹤0.01% | 3796 |
|
|
2021
Q1 | $584K | Buy |
19,326
+12,511
| +184% | +$378K | ﹤0.01% | 3673 |
|
|
2020
Q4 | $337K | Buy |
6,815
+1,501
| +28% | +$74.2K | ﹤0.01% | 3796 |
|
|
2020
Q3 | $204K | Sell |
5,314
-63
| -1% | -$2.42K | ﹤0.01% | 3875 |
|
|
2020
Q2 | $232K | Sell |
5,377
-7,253
| -57% | -$313K | ﹤0.01% | 3592 |
|
|
2020
Q1 | $330K | Buy |
+12,630
| New | +$330K | ﹤0.01% | 3332 |
|
|
2019
Q4 | – | Sell |
-8,974
| Closed | -$234K | – | 4932 |
|
|
2019
Q3 | $234K | Buy |
+8,974
| New | +$234K | ﹤0.01% | 3690 |
|